Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.
Use this FULC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FULC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FULC SEC filings page. Lician reads the product cache first so this HTML stays unique to Fulcrum Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full FULC income, balance, and cash tables.